Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 161

1.

Specificity of Morbillivirus Hemagglutinins to Recognize SLAM of Different Species.

Fukuhara H, Ito Y, Sako M, Kajikawa M, Yoshida K, Seki F, Mwaba MH, Hashiguchi T, Higashibata MA, Ose T, Kuroki K, Takeda M, Maenaka K.

Viruses. 2019 Aug 19;11(8). pii: E761. doi: 10.3390/v11080761.

2.

Novel Notch signaling inhibitor NSI‑1 suppresses nuclear translocation of the Notch intracellular domain.

Shiraishi T, Sakaitani M, Otsuguro S, Maenaka K, Suzuki T, Nakaya T.

Int J Mol Med. 2019 Jul 19. doi: 10.3892/ijmm.2019.4280. [Epub ahead of print]

PMID:
31364722
3.

Biophysical characterization and single-chain Fv construction of a neutralizing antibody to measles virus.

Tadokoro T, Jahan ML, Ito Y, Tahara M, Chen S, Imai A, Sugimura N, Yoshida K, Saito M, Ose T, Hashiguchi T, Takeda M, Fukuhara H, Maenaka K.

FEBS J. 2019 Jul 9. doi: 10.1111/febs.14991. [Epub ahead of print]

PMID:
31287622
4.

Identification of IgG1 Aggregation Initiation Region by Hydrogen Deuterium Mass Spectrometry.

Noda M, Ishii K, Yamauchi M, Oyama H, Tadokoro T, Maenaka K, Torisu T, Uchiyama S.

J Pharm Sci. 2019 Jul;108(7):2323-2333. doi: 10.1016/j.xphs.2019.02.023. Epub 2019 Mar 6.

PMID:
30851343
5.

HLA-G dimer targets Granzyme B pathway to prolong human renal allograft survival.

Ajith A, Portik-Dobos V, Nguyen-Lefebvre AT, Callaway C, Horuzsko DD, Kapoor R, Zayas C, Maenaka K, Mulloy LL, Horuzsko A.

FASEB J. 2019 Apr;33(4):5220-5236. doi: 10.1096/fj.201802017R. Epub 2019 Jan 8.

PMID:
30620626
6.

Synthesis of glycerolipids containing simple linear acyl chains or aromatic rings and evaluation of their Mincle signaling activity.

Matsumaru T, Ikeno R, Shuchi Y, Iwamatsu T, Tadokoro T, Yamasaki S, Fujimoto Y, Furukawa A, Maenaka K.

Chem Commun (Camb). 2019 Jan 10;55(5):711-714. doi: 10.1039/c8cc07322h.

PMID:
30566122
7.

Crystal structure of the complex between venom toxin and serum inhibitor from Viperidae snake.

Shioi N, Tadokoro T, Shioi S, Okabe Y, Matsubara H, Kita S, Ose T, Kuroki K, Terada S, Maenaka K.

J Biol Chem. 2019 Jan 25;294(4):1250-1256. doi: 10.1074/jbc.RA118.006840. Epub 2018 Nov 30.

PMID:
30504218
8.

Repurposing existing drugs: identification of irreversible IMPDH inhibitors by high-throughput screening.

Sarwono AEY, Mitsuhashi S, Kabir MHB, Shigetomi K, Okada T, Ohsaka F, Otsuguro S, Maenaka K, Igarashi M, Kato K, Ubukata M.

J Enzyme Inhib Med Chem. 2019 Dec;34(1):171-178. doi: 10.1080/14756366.2018.1540474.

9.

Suramin, screened from an approved drug library, inhibits HuR functions and attenuates malignant phenotype of oral cancer cells.

Kakuguchi W, Nomura T, Kitamura T, Otsuguro S, Matsushita K, Sakaitani M, Maenaka K, Tei K.

Cancer Med. 2018 Dec;7(12):6269-6280. doi: 10.1002/cam4.1877. Epub 2018 Nov 18.

10.

Structure of MHC class I-like MILL2 reveals heparan-sulfate binding and interdomain flexibility.

Kajikawa M, Ose T, Fukunaga Y, Okabe Y, Matsumoto N, Yonezawa K, Shimizu N, Kollnberger S, Kasahara M, Maenaka K.

Nat Commun. 2018 Oct 18;9(1):4330. doi: 10.1038/s41467-018-06797-8.

11.

Structural insights into modulation and selectivity of transsynaptic neurexin-LRRTM interaction.

Yamagata A, Goto-Ito S, Sato Y, Shiroshima T, Maeda A, Watanabe M, Saitoh T, Maenaka K, Terada T, Yoshida T, Uemura T, Fukai S.

Nat Commun. 2018 Sep 27;9(1):3964. doi: 10.1038/s41467-018-06333-8.

12.

A Sialylated Voltage-Dependent Ca2+ Channel Binds Hemagglutinin and Mediates Influenza A Virus Entry into Mammalian Cells.

Fujioka Y, Nishide S, Ose T, Suzuki T, Kato I, Fukuhara H, Fujioka M, Horiuchi K, Satoh AO, Nepal P, Kashiwagi S, Wang J, Horiguchi M, Sato Y, Paudel S, Nanbo A, Miyazaki T, Hasegawa H, Maenaka K, Ohba Y.

Cell Host Microbe. 2018 Jun 13;23(6):809-818.e5. doi: 10.1016/j.chom.2018.04.015. Epub 2018 May 17.

13.

Ribavirin-related compounds exert in vitro inhibitory effects toward rabies virus.

Anindita PD, Sasaki M, Okada K, Ito N, Sugiyama M, Saito-Tarashima N, Minakawa N, Shuto S, Otsuguro S, Ichikawa S, Matsuda A, Maenaka K, Orba Y, Sawa H.

Antiviral Res. 2018 Jun;154:1-9. doi: 10.1016/j.antiviral.2018.03.011. Epub 2018 Mar 28.

14.

The Role of Heparan Sulfate Proteoglycans as an Attachment Factor for Rabies Virus Entry and Infection.

Sasaki M, Anindita PD, Ito N, Sugiyama M, Carr M, Fukuhara H, Ose T, Maenaka K, Takada A, Hall WW, Orba Y, Sawa H.

J Infect Dis. 2018 May 5;217(11):1740-1749. doi: 10.1093/infdis/jiy081.

15.

X-ray crystal structure of Escherichia coli HspQ, a protein involved in the retardation of replication initiation.

Abe Y, Shioi S, Kita S, Nakata H, Maenaka K, Kohda D, Katayama T, Ueda T.

FEBS Lett. 2017 Nov;591(22):3805-3816. doi: 10.1002/1873-3468.12892. Epub 2017 Nov 12.

16.

The Roles of Matricellular Proteins in Oncogenic Virus-Induced Cancers and Their Potential Utilities as Therapeutic Targets.

Maeda N, Maenaka K.

Int J Mol Sci. 2017 Oct 21;18(10). pii: E2198. doi: 10.3390/ijms18102198. Review.

17.

Structural and thermodynamic analyses reveal critical features of glycopeptide recognition by the human PILRα immune cell receptor.

Furukawa A, Kakita K, Yamada T, Ishizuka M, Sakamoto J, Hatori N, Maeda N, Ohsaka F, Saitoh T, Nomura T, Kuroki K, Nambu H, Arase H, Matsunaga S, Anada M, Ose T, Hashimoto S, Maenaka K.

J Biol Chem. 2017 Dec 22;292(51):21128-21136. doi: 10.1074/jbc.M117.799239. Epub 2017 Oct 18.

18.

Production of Single-Chain Fv Antibodies Specific for GA-Pyridine, an Advanced Glycation End-Product (AGE), with Reduced Inter-Domain Motion.

Fukuda N, Noi K, Weng L, Kobashigawa Y, Miyazaki H, Wakeyama Y, Takaki M, Nakahara Y, Tatsuno Y, Uchida-Kamekura M, Suwa Y, Sato T, Ichikawa-Tomikawa N, Nomizu M, Fujiwara Y, Ohsaka F, Saitoh T, Maenaka K, Kumeta H, Shinya S, Kojima C, Ogura T, Morioka H.

Molecules. 2017 Oct 10;22(10). pii: E1695. doi: 10.3390/molecules22101695.

19.

Therapeutic application of human leukocyte antigen-G1 improves atopic dermatitis-like skin lesions in mice.

Maeda N, Yamada C, Takahashi A, Kuroki K, Maenaka K.

Int Immunopharmacol. 2017 Sep;50:202-207. doi: 10.1016/j.intimp.2017.06.026. Epub 2017 Jul 1.

20.

Molecular basis of selective mitochondrial fusion by heterotypic action between OPA1 and cardiolipin.

Ban T, Ishihara T, Kohno H, Saita S, Ichimura A, Maenaka K, Oka T, Mihara K, Ishihara N.

Nat Cell Biol. 2017 Jul;19(7):856-863. doi: 10.1038/ncb3560. Epub 2017 Jun 19.

PMID:
28628083
21.

Divergent synthesis of kinase inhibitor derivatives, leading to discovery of selective Gck inhibitors.

Matsumaru T, Inai M, Ishigami K, Iwamatsu T, Maita H, Otsuguro S, Nomura T, Matsuda A, Ichikawa S, Sakaitani M, Shuto S, Maenaka K, Kan T.

Bioorg Med Chem Lett. 2017 May 15;27(10):2144-2147. doi: 10.1016/j.bmcl.2017.03.055. Epub 2017 Mar 23.

22.

Cutting Edge: Class II-like Structural Features and Strong Receptor Binding of the Nonclassical HLA-G2 Isoform Homodimer.

Kuroki K, Mio K, Takahashi A, Matsubara H, Kasai Y, Manaka S, Kikkawa M, Hamada D, Sato C, Maenaka K.

J Immunol. 2017 May 1;198(9):3399-3403. doi: 10.4049/jimmunol.1601296. Epub 2017 Mar 27.

23.

A trimeric structural fusion of an antagonistic tumor necrosis factor-α mutant enhances molecular stability and enables facile modification.

Inoue M, Ando D, Kamada H, Taki S, Niiyama M, Mukai Y, Tadokoro T, Maenaka K, Nakayama T, Kado Y, Inoue T, Tsutsumi Y, Tsunoda SI.

J Biol Chem. 2017 Apr 21;292(16):6438-6451. doi: 10.1074/jbc.M117.779686. Epub 2017 Feb 24.

24.

HIV-1 Control by NK Cells via Reduced Interaction between KIR2DL2 and HLA-C12:02/C14:03.

Lin Z, Kuroki K, Kuse N, Sun X, Akahoshi T, Qi Y, Chikata T, Naruto T, Koyanagi M, Murakoshi H, Gatanaga H, Oka S, Carrington M, Maenaka K, Takiguchi M.

Cell Rep. 2016 Nov 22;17(9):2210-2220. doi: 10.1016/j.celrep.2016.10.075.

25.

Erratum: Tahara, M., et al. Measles Virus Hemagglutinin Protein Epitopes: The Basis of Antigenic Stability. Viruses 2016, 8, 216.

Tahara M, Bürckert JP, Kanou K, Maenaka K, Muller CP, Takeda M.

Viruses. 2016 Nov 21;8(11). pii: E313.

26.

Rapid Screening by Cell-Based Fusion Assay for Identifying Novel Antivirals of Glycoprotein B-Mediated Herpes Simplex Virus Type 1 Infection.

Maeda N, Furukawa A, Kakita K, Anada M, Hashimoto S, Matsunaga S, Kuroki K, Ose T, Kato A, Arii J, Kawaguchi Y, Arase H, Maenaka K.

Biol Pharm Bull. 2016;39(11):1897-1902.

27.

Isolated Polar Amino Acid Residues Modulate Lipid Binding in the Large Hydrophobic Cavity of CD1d.

Inuki S, Aiba T, Hirata N, Ichihara O, Yoshidome D, Kita S, Maenaka K, Fukase K, Fujimoto Y.

ACS Chem Biol. 2016 Nov 18;11(11):3132-3139. Epub 2016 Oct 4.

PMID:
27648599
28.

Measles Virus Hemagglutinin Protein Epitopes: The Basis of Antigenic Stability.

Tahara M, Bürckert JP, Kanou K, Maenaka K, Muller CP, Takeda M.

Viruses. 2016 Aug 2;8(8). pii: E216. doi: 10.3390/v8080216. Review. Erratum in: Viruses. 2016 Nov 21;8(11):null.

29.

Establishment of the BacMam system using silkworm baculovirus.

Imai A, Tadokoro T, Kita S, Horiuchi M, Fukuhara H, Maenaka K.

Biochem Biophys Res Commun. 2016 Sep 16;478(2):580-5. doi: 10.1016/j.bbrc.2016.07.104. Epub 2016 Jul 29.

PMID:
27480929
30.

Synthesis and Th1-immunostimulatory activity of α-galactosylceramide analogues bearing a halogen-containing or selenium-containing acyl chain.

Hossain MI, Hanashima S, Nomura T, Lethu S, Tsuchikawa H, Murata M, Kusaka H, Kita S, Maenaka K.

Bioorg Med Chem. 2016 Aug 15;24(16):3687-95. doi: 10.1016/j.bmc.2016.06.007. Epub 2016 Jun 6.

PMID:
27325450
31.

Chemical Screening Identifies EUrd as a Novel Inhibitor Against Temozolomide-Resistant Glioblastoma-Initiating Cells.

Tsukamoto Y, Ohtsu N, Echizenya S, Otsuguro S, Ogura R, Natsumeda M, Isogawa M, Aoki H, Ichikawa S, Sakaitani M, Matsuda A, Maenaka K, Fujii Y, Kondo T.

Stem Cells. 2016 Aug;34(8):2016-25. doi: 10.1002/stem.2380. Epub 2016 May 17.

32.

Ribophorin II is involved in the tissue factor expression mediated by phosphatidylserine-dependent antiprothrombin antibody on monocytes.

Fujieda Y, Amengual O, Matsumoto M, Kuroki K, Takahashi H, Kono M, Kurita T, Otomo K, Kato M, Oku K, Bohgaki T, Horita T, Yasuda S, Maenaka K, Hatakeyama S, Nakayama KI, Atsumi T.

Rheumatology (Oxford). 2016 Jun;55(6):1117-26. doi: 10.1093/rheumatology/kew005. Epub 2016 Feb 19.

PMID:
26895716
33.

The immunosuppressive effect of domain-deleted dimer of HLA-G2 isoform in collagen-induced arthritis mice.

Takahashi A, Kuroki K, Okabe Y, Kasai Y, Matsumoto N, Yamada C, Takai T, Ose T, Kon S, Matsuda T, Maenaka K.

Hum Immunol. 2016 Sep;77(9):754-9. doi: 10.1016/j.humimm.2016.01.010. Epub 2016 Jan 21.

34.

Large displacement haptic stimulus actuator using piezoelectric pump for wearable devices.

Kodama T, Izumi S, Masaki K, Kawaguchi H, Maenaka K, Yoshimoto M.

Conf Proc IEEE Eng Med Biol Soc. 2015 Aug;2015:1172-5. doi: 10.1109/EMBC.2015.7318575.

PMID:
26736475
35.

Osteopontin-integrin interaction as a novel molecular target for antibody-mediated immunotherapy in adult T-cell leukemia.

Maeda N, Ohashi T, Chagan-Yasutan H, Hattori T, Takahashi Y, Harigae H, Hasegawa H, Yamada Y, Fujii M, Maenaka K, Uede T.

Retrovirology. 2015 Nov 24;12:99. doi: 10.1186/s12977-015-0225-x.

36.

The cell competition-based high-throughput screening identifies small compounds that promote the elimination of RasV12-transformed cells from epithelia.

Yamauchi H, Matsumaru T, Morita T, Ishikawa S, Maenaka K, Takigawa I, Semba K, Kon S, Fujita Y.

Sci Rep. 2015 Oct 20;5:15336. doi: 10.1038/srep15336.

37.

Solution structure of an avirulence protein, AVR-Pia, from Magnaporthe oryzae.

Ose T, Oikawa A, Nakamura Y, Maenaka K, Higuchi Y, Satoh Y, Fujiwara S, Demura M, Sone T, Kamiya M.

J Biomol NMR. 2015 Oct;63(2):229-35. doi: 10.1007/s10858-015-9979-7. Epub 2015 Sep 11. No abstract available.

PMID:
26362280
38.

Screening for FtsZ Dimerization Inhibitors Using Fluorescence Cross-Correlation Spectroscopy and Surface Resonance Plasmon Analysis.

Mikuni S, Kodama K, Sasaki A, Kohira N, Maki H, Munetomo M, Maenaka K, Kinjo M.

PLoS One. 2015 Jul 8;10(7):e0130933. doi: 10.1371/journal.pone.0130933. eCollection 2015.

39.

Effect of hydrophobic scaffold on the cellular uptake and gene transfection activities of DNA-encapsulating liposomal nanoparticles via intracerebroventricular administration.

Akita H, Nakatani T, Kuroki K, Maenaka K, Tange K, Nakai Y, Harashima H.

Int J Pharm. 2015 Jul 25;490(1-2):142-5. doi: 10.1016/j.ijpharm.2015.05.043. Epub 2015 May 21.

PMID:
26003418
40.

Crystal structure of extracellular domain of human lectin-like transcript 1 (LLT1), the ligand for natural killer receptor-P1A.

Kita S, Matsubara H, Kasai Y, Tamaoki T, Okabe Y, Fukuhara H, Kamishikiryo J, Krayukhina E, Uchiyama S, Ose T, Kuroki K, Maenaka K.

Eur J Immunol. 2015 Jun;45(6):1605-13. doi: 10.1002/eji.201545509. Epub 2015 Apr 28.

41.

Heat shock protein 70 regulates degradation of the mumps virus phosphoprotein via the ubiquitin-proteasome pathway.

Katoh H, Kubota T, Kita S, Nakatsu Y, Aoki N, Mori Y, Maenaka K, Takeda M, Kidokoro M.

J Virol. 2015 Mar;89(6):3188-99. doi: 10.1128/JVI.03343-14. Epub 2014 Dec 31.

42.

The structural basis for receptor recognition of human interleukin-18.

Tsutsumi N, Kimura T, Arita K, Ariyoshi M, Ohnishi H, Yamamoto T, Zuo X, Maenaka K, Park EY, Kondo N, Shirakawa M, Tochio H, Kato Z.

Nat Commun. 2014 Dec 15;5:5340. doi: 10.1038/ncomms6340.

43.

New binding face of C-type lectin-like domains.

Fukuhara H, Furukawa A, Maenaka K.

Structure. 2014 Dec 2;22(12):1694-1696. doi: 10.1016/j.str.2014.11.001.

44.

Efficient and cost effective production of active-form human PKB using silkworm larvae.

Maesaki R, Satoh R, Taoka M, Kanaba T, Asano T, Fujita C, Fujiwara T, Ito Y, Isobe T, Hakoshima T, Maenaka K, Mishima M.

Sci Rep. 2014 Aug 15;4:6016. doi: 10.1038/srep06016.

45.

The N-terminal Arg residue is essential for autocatalytic activation of a lipopolysaccharide-responsive protease zymogen.

Kobayashi Y, Shiga T, Shibata T, Sako M, Maenaka K, Koshiba T, Mizumura H, Oda T, Kawabata S.

J Biol Chem. 2014 Sep 12;289(37):25987-95. doi: 10.1074/jbc.M114.586933. Epub 2014 Jul 30.

46.

Heterologous production, purification, and immunodetection of Magnaporthe oryzae avirulence protein AVR-Pia.

Satoh Y, Miki S, Ose T, Oikawa A, Maenaka K, Terauchi R, Asano K, Sone T.

Biosci Biotechnol Biochem. 2014;78(4):680-6. doi: 10.1080/09168451.2014.893186. Epub 2014 May 16.

PMID:
25036967
47.

Structural basis for simultaneous recognition of an O-glycan and its attached peptide of mucin family by immune receptor PILRα.

Kuroki K, Wang J, Ose T, Yamaguchi M, Tabata S, Maita N, Nakamura S, Kajikawa M, Kogure A, Satoh T, Arase H, Maenaka K.

Proc Natl Acad Sci U S A. 2014 Jun 17;111(24):8877-82. doi: 10.1073/pnas.1324105111. Epub 2014 Jun 2.

48.

The host protease TMPRSS2 plays a major role in in vivo replication of emerging H7N9 and seasonal influenza viruses.

Sakai K, Ami Y, Tahara M, Kubota T, Anraku M, Abe M, Nakajima N, Sekizuka T, Shirato K, Suzaki Y, Ainai A, Nakatsu Y, Kanou K, Nakamura K, Suzuki T, Komase K, Nobusawa E, Maenaka K, Kuroda M, Hasegawa H, Kawaoka Y, Tashiro M, Takeda M.

J Virol. 2014 May;88(10):5608-16. doi: 10.1128/JVI.03677-13. Epub 2014 Mar 5.

49.

Crystal structure of the lamprey variable lymphocyte receptor C reveals an unusual feature in its N-terminal capping module.

Kanda R, Sutoh Y, Kasamatsu J, Maenaka K, Kasahara M, Ose T.

PLoS One. 2014 Jan 23;9(1):e85875. doi: 10.1371/journal.pone.0085875. eCollection 2014.

50.

Allosteric regulation of epoxide opening cascades by a pair of epoxide hydrolases in monensin biosynthesis.

Minami A, Ose T, Sato K, Oikawa A, Kuroki K, Maenaka K, Oguri H, Oikawa H.

ACS Chem Biol. 2014 Feb 21;9(2):562-9. doi: 10.1021/cb4006485. Epub 2013 Dec 13.

PMID:
24320215

Supplemental Content

Loading ...
Support Center